
Videos
Advertisement
Advertisement
Trending on Pharmacy Times
1
Expert Discusses Early Safety and Tolerability Findings for VMT-α-NET in Neuroendocrine Tumors | ESMO 2025
2
Five-Year NATALEE Data Show Ribociclib Improves Outcomes in High-Risk HR+/HER2– Early Breast Cancer
3
Emerging Use of an Allosteric TKI: Asciminib for the Treatment of Chronic Myeloid Leukemia
4
Durvalumab Plus Chemotherapy Sets New Standard in Resectable Gastric and GEJ Cancer
5